Medical devices, healthcare technology and the business of care
PMA approval · P880047

INTERCEED TC7 ABSORBABLE ADHESION BARRIER

ETHICON, Inc. · Decision date Sep 15, 1989

FDA DECISIONP880047

What did the FDA approve?

FDA records P880047 as an original PMA application. The recorded decision is approval, dated Sep 15, 1989.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
Obstetrics/Gynecology
Decision date
Sep 15, 1989

FDA source record

Regulatory record facts

Identifier
P880047
Regulatory pathway
Premarket approval application
Applicant
ETHICON, Inc.
Product code
MCN
Decision code
APPR
Decision date
Sep 15, 1989
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Barrier, absorbable, adhesion.

Applicant
ETHICON, Inc.
Product code
MCN
FDA device class
3

FDA decision timeline

  1. P880047 received

    Application receipt date recorded by FDA.

  2. P880047 · FDA decision

    APPR

  3. P880047/S072 · Related supplement

    GYNECARE INTERCEED Absorbable Adhesion Barrier

Timeline entries are records held by MedtechLedger for P880047. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P880047

Product / regulatory recordCompanyPathwayDecision dateSource
ETHICON, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code MCN

Product / regulatory recordCompanyPathwayDecision dateSource
Rejoni, Inc.PMA supplementOct 28, 2026FDA
Womed LeafP240015/S003
Womed SasPMA supplementOct 25, 2026FDA
Rejoni, Inc.PMA approvalSep 28, 2026FDA
Womed SasPMA approvalSep 9, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ETHICON, Inc.

Headquarters
Not reported
Brand website
ethicon.com
FDA applicant address
1000 Rte. 202, Raritan, NJ, 08869

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records